These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 11074805)

  • 1. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes.
    Kunert KS; Tisdale AS; Stern ME; Smith JA; Gipson IK
    Arch Ophthalmol; 2000 Nov; 118(11):1489-96. PubMed ID: 11074805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine.
    Kunert KS; Tisdale AS; Gipson IK
    Arch Ophthalmol; 2002 Mar; 120(3):330-7. PubMed ID: 11879137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis.
    Hingorani M; Calder VL; Buckley RJ; Lightman S
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):392-9. PubMed ID: 9950598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response in the conjunctival epithelium of patients with dry eye.
    Barabino S; Montaldo E; Solignani F; Valente C; Mingari MC; Rolando M
    Exp Eye Res; 2010 Oct; 91(4):524-9. PubMed ID: 20654615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.
    Brignole F; Pisella PJ; De Saint Jean M; Goldschild M; Goguel A; Baudouin C
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):90-5. PubMed ID: 11133852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion.
    Turner K; Pflugfelder SC; Ji Z; Feuer WJ; Stern M; Reis BL
    Cornea; 2000 Jul; 19(4):492-6. PubMed ID: 10928765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes.
    Brignole F; Pisella PJ; Goldschild M; De Saint Jean M; Goguel A; Baudouin C
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1356-63. PubMed ID: 10798650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease.
    Huang JF; Yafawi R; Zhang M; McDowell M; Rittenhouse KD; Sace F; Liew SH; Cooper SR; Pickering EH
    Ophthalmology; 2012 Jul; 119(7):e43-50. PubMed ID: 22607938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conjunctival epithelium in dry eye subtypes: effect of preserved and non-preserved topical treatments.
    Albietz JM; Bruce AS
    Curr Eye Res; 2001 Jan; 22(1):8-18. PubMed ID: 11402374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study.
    Avunduk AM; Avunduk MC; Varnell ED; Kaufman HE
    Am J Ophthalmol; 2003 Oct; 136(4):593-602. PubMed ID: 14516798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of topical cyclosporine a plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome.
    Demiryay E; Yaylali V; Cetin EN; Yildirim C
    Eye Contact Lens; 2011 Sep; 37(5):312-5. PubMed ID: 21792057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
    Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
    Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis.
    el-Asrar AM; Tabbara KF; Geboes K; Missotten L; Desmet V
    Am J Ophthalmol; 1996 Feb; 121(2):156-61. PubMed ID: 8623884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.
    Strong B; Farley W; Stern ME; Pflugfelder SC
    Cornea; 2005 Jan; 24(1):80-5. PubMed ID: 15604871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis.
    Avunduk AM; Avunduk MC; Erdöl H; Kapicioglu Z; Akyol N
    Ophthalmologica; 2001; 215(4):290-3. PubMed ID: 11399937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometry in impression cytology during keratoconjunctivitis sicca: effects of topical cyclosporin A on HLA DR expression].
    Galatoire O; Baudouin C; Pisella PJ; Brignole F
    J Fr Ophtalmol; 2003 Apr; 26(4):337-43. PubMed ID: 12843889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye.
    Stern ME; Gao J; Schwalb TA; Ngo M; Tieu DD; Chan CC; Reis BL; Whitcup SM; Thompson D; Smith JA
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2609-14. PubMed ID: 12147592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Application of Mizoribine Suppresses CD4+ T-cell-Mediated Pathogenesis in Murine Dry Eye.
    Zhang X; Lin X; Liu Z; Wu Y; Yang Y; Ouyang W; Li W; Liu Z
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6056-6064. PubMed ID: 29204644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eye.
    Gehlsen U; Braun T; Notara M; Krösser S; Steven P
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):767-775. PubMed ID: 28091781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.